MedTrace Logo

LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT

NCT05919641 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2023-06-26

No results posted yet for this study

Summary

Older patients with non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) often die from other causes than lung cancer due to age-related comorbidities. This national randomized study will include 130 patients throughout 5 Danish cancer centres and investigate if a comprehensive geriatric intervention (CGA) when added upfront to SBRT for patients with localized NSCLC will have an impact on quality of life (QoL), overall survival, physical functionality and unplanned hospital admissions.

If an upfront CGA improves patients' general health status, this study could lead to implementation of a CGA in standard clinical practice as well as further research on older patients receiving radiotherapy.

Conditions

Interventions

OTHER

Comprehensive Geriatric Assessment

Comprehensive geriatric assessment (CGA) is defined as a multidisciplinary diagnostic and treatment process that identifies medical, psychosocial, and functional capabilities of an older adult in order to develop a coordinated plan to maximize overall health with aging.

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Kristian K Bentsen, Dr. med · Department of Oncology, Odense University Hospital, Denmark

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-29
Primary Completion
2024-04-01
Completion
2025-04-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05919641 on ClinicalTrials.gov